Notice for pimicotinib (as hydrochloride hydrate) (Merck Healthcare Pty Ltd)
Active ingredients
pimicotinib (as hydrochloride hydrate)
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
capsule
Indication
For the treatment of tenosynovial giant cell tumour
Therapeutic area
Oncology